317 related articles for article (PubMed ID: 30797486)
1. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
[TBL] [Abstract][Full Text] [Related]
2. [Computed tomography findings, clinicopathological features, genetic characteristics and prognosis of
Shen L; Lin J; Wang B; Xu H; Zhao K; Zhang L
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Sep; 39(9):1107-1112. PubMed ID: 31640952
[TBL] [Abstract][Full Text] [Related]
3. A clinicopathological study of lung adenocarcinomas with pure ground-glass opacity > 3 cm on high-resolution computed tomography.
Sun K; Xie H; Zhao J; Wang B; Bao X; Zhou F; Zhang L; Li W
Eur Radiol; 2022 Jan; 32(1):174-183. PubMed ID: 34132876
[TBL] [Abstract][Full Text] [Related]
4. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.
Liu Y; Sun H; Zhou F; Su C; Gao G; Ren S; Zhou C; Zhang Z; Shi J
Lung Cancer; 2017 Jun; 108():192-197. PubMed ID: 28625634
[TBL] [Abstract][Full Text] [Related]
5. HRCT features distinguishing pre-invasive from invasive pulmonary adenocarcinomas appearing as ground-glass nodules.
Zhang Y; Shen Y; Qiang JW; Ye JD; Zhang J; Zhao RY
Eur Radiol; 2016 Sep; 26(9):2921-8. PubMed ID: 26662263
[TBL] [Abstract][Full Text] [Related]
6. HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma.
Yagi T; Yamazaki M; Ohashi R; Ogawa R; Ishikawa H; Yoshimura N; Tsuchida M; Ajioka Y; Aoyama H
Jpn J Radiol; 2018 Feb; 36(2):113-121. PubMed ID: 29273964
[TBL] [Abstract][Full Text] [Related]
7. Surgery for pre- and minimally invasive lung adenocarcinoma.
Zhang Y; Ma X; Shen X; Wang S; Li Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):456-464. PubMed ID: 33485660
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor mutations in adenocarcinoma in situ and minimally invasive adenocarcinoma detected using mutation-specific monoclonal antibodies.
Nakamura H; Koizumi H; Kimura H; Marushima H; Saji H; Takagi M
Lung Cancer; 2016 Sep; 99():143-7. PubMed ID: 27565930
[TBL] [Abstract][Full Text] [Related]
9. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
[TBL] [Abstract][Full Text] [Related]
10. CT Characteristics for Predicting Invasiveness in Pulmonary Pure Ground-Glass Nodules.
Chu ZG; Li WJ; Fu BJ; Lv FJ
AJR Am J Roentgenol; 2020 Aug; 215(2):351-358. PubMed ID: 32348187
[No Abstract] [Full Text] [Related]
11. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients.
Jia M; Yu S; Cao L; Sun PL; Gao H
Ann Surg Oncol; 2020 Aug; 27(8):3052-3063. PubMed ID: 32048092
[TBL] [Abstract][Full Text] [Related]
13. HRCT morphological characteristics distinguishing minimally invasive pulmonary adenocarcinoma from invasive pulmonary adenocarcinoma appearing as subsolid nodules with a diameter of ≤3 cm.
Yue X; Liu S; Liu S; Yang G; Li Z; Wang B; Zhou Q
Clin Radiol; 2018 Apr; 73(4):411.e7-411.e15. PubMed ID: 29273229
[TBL] [Abstract][Full Text] [Related]
14. CT-texture analysis of subsolid nodules for differentiating invasive from in-situ and minimally invasive lung adenocarcinoma subtypes.
Cohen JG; Reymond E; Medici M; Lederlin M; Lantuejoul S; Laurent F; Toffart AC; Moreau-Gaudry A; Jankowski A; Ferretti GR
Diagn Interv Imaging; 2018 May; 99(5):291-299. PubMed ID: 29477490
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung.
Yotsukura M; Asamura H; Motoi N; Kashima J; Yoshida Y; Nakagawa K; Shiraishi K; Kohno T; Yatabe Y; Watanabe SI
J Thorac Oncol; 2021 Aug; 16(8):1312-1320. PubMed ID: 33915249
[TBL] [Abstract][Full Text] [Related]
16. Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative.
Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1614-1622.e1. PubMed ID: 35965138
[TBL] [Abstract][Full Text] [Related]
17. High-resolution computed tomography findings of early mucinous adenocarcinomas and their pathologic characteristics in 22 surgically resected cases.
Miyata N; Endo M; Nakajima T; Kojima H; Maniwa T; Takahashi S; Isaka M; Kameya T; Ohde Y
Eur J Radiol; 2015 May; 84(5):993-7. PubMed ID: 25681135
[TBL] [Abstract][Full Text] [Related]
18. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma.
Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T
Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966
[TBL] [Abstract][Full Text] [Related]
19. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.
Naito M; Aokage K; Saruwatari K; Hisakane K; Miyoshi T; Hishida T; Yoshida J; Masato S; Kojima M; Kuwata T; Fujii S; Ochiai A; Sato Y; Tsuboi M; Ishii G
Lung Cancer; 2016 Oct; 100():53-62. PubMed ID: 27597281
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules.
She Y; Zhang L; Zhu H; Dai C; Xie D; Xie H; Zhang W; Zhao L; Zou L; Fei K; Sun X; Chen C
Eur Radiol; 2018 Dec; 28(12):5121-5128. PubMed ID: 29869172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
